Pune, India, April 18, 2019 -- /360iResearch/ -- The report "Global Female Fertility & Pregnancy Rapid Test Market - Premium Insight, Industry Trends, FPNV Positioning Matrix, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025 (Q1 2019 Update)", published by 360iResearch, states that the global market was valued at USD 1.29 billion in 2018 and is projected to reach USD 2.48 billion by 2025, growing at a CAGR of 9.79% from 2018 to 2025.
The major forces driving the growth of the female fertility & pregnancy rapid test market include the rising demand for the quick and self-contained test than the time-consuming lab-based test and growing incidence of infertility and gynecological disorders. However absurdity of choice due to the availability of too many options, and controversies and device related issues may hinder the market growth. In the middle of difficulty lies opportunity such as the technological advancements and attractive product features such as smartphone app connectivity, and increasing awareness about the kits in the developing economies. The possible challenges for the market growth is availability of alternative diagnostic tests, such as blood test and reagent-based laboratory test with fewer chances of error. But key players in the market are overcoming the challenges with continual improvement and innovation.
Based on device type, the global female fertility & pregnancy rapid test market is studied across Digital Devices, and Line-indicator Devices. Based on test type, the global female fertility & pregnancy rapid test market is studied across FSH Urine Test, LH Urine Test, hCG Blood Test, and hCG Urine Test. Based on type, the global female fertility & pregnancy rapid test market is studied across Fertility Rapid Test Kits, and Pregnancy Rapid Test Kits. Based on distribution channel, the global female fertility & pregnancy rapid test market is studied across Drugstores, Gynecology & fertility clinics, Hypermarkets & supermarkets, Online, and Pharmacies. Based on geography, the global female fertility & pregnancy rapid test market is studied across Americas, Europe, Middle East & Africa, and Asia-Pacific.
The report features a competitive scenario of the female fertility & pregnancy rapid test market and provides inclusive analysis of key growth strategies adopted by major players. Key company profiled in the study are Abbott Laboratories, Alere Inc., Atlas Medical Software, Church & Dwight Co., Inc., DCC plc, Geratherm Medical AG, Nantong Egens Biotechnology Co., Ltd., Prestige Consumer Healthcare Inc., Procter & Gamble Inc., Quidel Corporation, SPD Swiss Precision Diagnostics GmBH, and bioMérieux S.A..
360iResearch LLP, headquartered in Pune, India, is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as Aerospace & Defense, Agriculture, Automotive & Transportation, Building, Construction & Real Estate, Chemicals & Advanced Material, Consumer Goods & Retail, Energy & Utilities, Food & Beverage, Healthcare & Life Sciences, Information Technology, Packaging, and Semiconductor & Electronics.
Miss. Shikha Sachan
India - 412207.
Email: [email protected]h.com